The Once-Daily Formulation of Tacrolimus: A Step Forward in Kidney Transplantation?

被引:25
作者
Hougardy, Jean-Michel [1 ]
de Jonge, Hylke [2 ]
Kuypers, Dirk [2 ]
Abramowicz, Daniel [1 ]
机构
[1] Clin Univ Hop Erasme, Dept Nephrol, Renal Transplantat Clin, B-1070 Brussels, Belgium
[2] Univ Hosp Leuven, Dept Nephrol & Renal Transplantat, Louvain, Belgium
关键词
Kidney transplantation; Tacrolimus; Formulations; PROGRAF-BASED REGIMEN; TWICE-DAILY PROGRAF; EXTENDED-RELEASE FORMULATION; 2 YEARS POSTCONVERSION; RENAL-TRANSPLANTATION; CONVERSION; RECIPIENTS; ADVAGRAF; PHARMACOKINETICS; NONADHERENCE;
D O I
10.1097/TP.0b013e31823aa56e
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Nonadherence is a critical issue in transplantation. Recently, Astellas designed a once-daily-extended release formulation of tacrolimus (Tac). Despite initial reports showing bioequivalence of Tac once-daily (Advagraf) with the original formulation requiring twice-daily intake (Tac twice-daily, Prograf), several groups have now shown a sustained decrease in Tac exposure upon conversion from Prograf to Advagraf. Here, we discuss the possible reasons for this observation and how it could affect the expected benefits of Advagraf, and we comment on the fact that a similar lack of bioequivalence might prevail with generic immunosuppressive drugs.
引用
收藏
页码:241 / 243
页数:3
相关论文
共 25 条
[11]   Reduced C0 Concentrations and Increased Dose Requirements in Renal Allograft Recipients Converted to the Novel Once-Daily Tacrolimus Formulation [J].
de Jonge, Hylke ;
Kuypers, Dirk R. ;
Verbeke, Kristin ;
Vanrenterghem, Yves .
TRANSPLANTATION, 2010, 90 (05) :523-529
[12]   Rates and risk factors for nonadherence to the medical regimen after adult solid organ transplantation [J].
Dew, Mary Amanda ;
DiMartini, Andrea F. ;
Dabbs, Annette De Vito ;
Myaskovsky, Larissa ;
Steel, Jennifer ;
Unruh, Mark ;
Switzer, Galen E. ;
Zomak, Rachelle ;
Kormos, Robert L. ;
Greenhouse, Joel B. .
TRANSPLANTATION, 2007, 83 (07) :858-873
[13]   Increased Adherence after Switch From Twice Daily Calcineurin Inhibitor Based Treatment to Once Daily Modified Released Tacrolimus in Heart Transplantation: A Pre-experimental Study [J].
Doesch, A. O. ;
Mueller, S. ;
Konstandin, M. ;
Celik, S. ;
Erbel, C. ;
Kristen, A. ;
Frankenstein, L. ;
Koch, A. ;
Dengler, T. J. ;
Ehlermann, P. ;
Zugck, C. ;
De Geest, S. ;
Katus, H. A. .
TRANSPLANTATION PROCEEDINGS, 2010, 42 (10) :4238-4242
[14]   KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients [J].
Eckardt, Kai-Uwe ;
Kasiske, Bertram L. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 :S1-S155
[15]  
European Medicines Agency, 2010, EUR PUBL ASS REP ADV
[16]  
European Medicines Agency. Committee for Medicinal Products for Human Use (CHMP), 2010, GUID INV BIOEQ CPMP
[17]   Conversion of stable liver transplant recipients from a twice-daily prograf-based regimen to a once-daily modified release tacrolimus-based regimen [J].
Florman, S ;
Alloway, R ;
Kalayoglu, M ;
Lake, K ;
Bak, T ;
Klein, A ;
Klintmalm, G ;
Busque, S ;
Brandenhagen, D ;
Lake, J ;
Wisemandle, K ;
Fitzsimmons, W ;
First, MR .
TRANSPLANTATION PROCEEDINGS, 2005, 37 (02) :1211-1213
[18]   Once-daily tacrolimus extended release formulation: Experience at 2 years postconversion from a Prograf-based regimen in stable liver transplant recipients [J].
Florman, Sander ;
Alloway, Rita ;
Kalayoglu, Munci ;
Punch, Jeffrey ;
Bak, Thomas ;
Melancon, Joseph ;
Klintmalm, Goran ;
Busque, Stephan ;
Charlton, Michael ;
Lake, John ;
Dhadda, Shobha ;
Wisemandle, Kathleen ;
Wirth, Mary ;
Fitzsimmons, William ;
Holman, John ;
First, M. Roy .
TRANSPLANTATION, 2007, 83 (12) :1639-1642
[19]   Conversion From Prograf to Advagraf Among Kidney Transplant Recipients Results in Sustained Decrease in Tacrolimus Exposure [J].
Hougardy, Jean-Michel ;
Broeders, Nilufer ;
Kianda, Mireille ;
Massart, Annick ;
Madhoun, Phillippe ;
Le Moine, Alain ;
Hoang, Anh-Dung ;
Mikhalski, Dimitri ;
Wissing, Karl M. ;
Abramowicz, Daniel .
TRANSPLANTATION, 2011, 91 (05) :566-569
[20]   Tacrolimus Once Daily (ADVAGRAF) Versus Twice Daily (PROGRAF) in De Novo Renal Transplantation: A Randomized Phase III Study [J].
Kraemer, B. K. ;
Charpentier, B. ;
Backman, L. ;
Silva, H. Tedesco, Jr. ;
Mondragon-Ramirez, G. ;
Cassuto-Viguier, E. ;
Mourad, G. ;
Sola, R. ;
Rigotti, P. ;
Ortuno Mirete, J. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 (12) :2632-2643